Integrating Therapeutic Ultrasound With Nanosized Drug Delivery Systems in the Battle Against Cancer.

Journal Information

Full Title: Technol Cancer Res Treat

Abbreviation: Technol Cancer Res Treat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by Toronto Poly Clinic Inc., Ontario Research Fund – Research Excellence (ORF-RE #RE02-032), an NSERC Banting Postdoctoral Fellowship (F. Moradi Kashkooli), an NSERC Alliance grant (ALLRP 556270-20), and NSERC Discovery grants that were awarded to J. Tavakkoli (RGPIN-2022-03799) and M. C. Kolios (RGPIN-2022-04143)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025